Advertisement
DHR vs MDT
Which Stock Would AI Choose? Danaher Corporation (DHR) vs. Medtronic plc (MDT) Stock Comparison
Key Takeaways
- Danaher Corporation (DHR) reported stronger recent quarterly results with an adjusted EPS beat in Q1 2026, while Medtronic plc (MDT) is scheduled to report fiscal Q4 results on June 3, 2026.
- Over recent weeks, DHR has shown relative outperformance with positive year-to-date returns compared to broader market benchmarks, whereas MDT has experienced more pronounced share price pressure.
- Both companies operate in the healthcare sector but with distinct focuses: DHR emphasizes life sciences and diagnostics tools, while MDT centers on medical devices across cardiovascular and surgical segments.
- Market sentiment reflects ongoing recovery in biotech end-markets for DHR, contrasted with MDT navigating portfolio expansion amid regulatory and demand variability.
- Valuation and momentum metrics position DHR with potentially greater near-term catalyst visibility, though both stocks carry exposure to healthcare spending trends and macroeconomic factors.
- Relative performance highlights trade-offs in growth stability versus established device market positioning.
Introduction
This comparison examines Danaher Corporation (DHR) and Medtronic plc (MDT), two established healthcare companies with significant market presence. Investors and traders evaluating sector allocation, relative momentum, or diversification within life sciences and medical technology may find this analysis relevant. The review focuses on observable business models, recent performance patterns, and market positioning to provide a factual basis for understanding their distinct profiles in the current environment.
DHR Overview and Recent Performance
Danaher Corporation (DHR) operates primarily in life sciences, diagnostics, and biotechnology platforms, supplying instruments and consumables that support research, clinical testing, and bioprocessing applications. In recent market activity, the stock has demonstrated resilience following its Q1 2026 earnings release, which featured an adjusted earnings per share (EPS) beat alongside modest core revenue growth. Broader sentiment has been influenced by gradual recovery signals in biotech end-markets, though the shares have traded below prior peaks amid sector-wide valuation adjustments. Recent weeks have seen mixed price behavior, with the company maintaining its dividend and participating in industry conferences that underscore operational continuity.
MDT Overview and Recent Performance
Medtronic plc (MDT) develops and manufactures medical devices spanning cardiovascular, diabetes, neurological, and surgical technologies. The company has faced share price softness in recent weeks as it approaches its fiscal Q4 2026 earnings release scheduled for June 3. Analysts project revenue growth alongside a modest year-over-year EPS decline. Market positioning reflects ongoing portfolio initiatives and demand across MedSurg and other segments, tempered by broader healthcare sector dynamics. Recent activity includes dividend adjustments and preparations for the upcoming results, with price behavior reflecting investor caution ahead of the report.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of AI trading bots from a much larger pool of hundreds available on the platform. These bots trade thousands of different tickers using varied strategies, timeframes, and performance statistics. Only those demonstrating the strongest alignment with prevailing market conditions earn placement in the trending section. Available bots span a wide range of risk profiles, historical returns, and ticker coverage, allowing users to explore diverse automated approaches. The platform highlights factual metrics such as win rates, profit factors, and drawdown statistics to inform selection. For additional details on current trending options, visit the Trending AI Robots page.
Head-to-Head Comparison
Danaher Corporation (DHR) and Medtronic plc (MDT) differ markedly in business models: DHR supplies precision tools and consumables for research and diagnostics, while MDT focuses on implantable and procedural medical devices. Growth drivers for DHR include bioprocessing demand and life sciences recovery, whereas MDT relies on device adoption, innovation pipelines, and procedural volumes. Recent momentum favors DHR following its earnings beat and relative year-to-date gains, contrasted with MDT’s steeper recent declines. Risk factors for both include healthcare reimbursement shifts and competitive pressures, with DHR showing greater exposure to research spending cycles and MDT to regulatory approvals and device recalls. Sector sentiment remains constructive for healthcare overall, though DHR’s positioning benefits from nearer-term catalyst visibility compared with MDT’s pre-earnings posture.
Tickeron AI Verdict
Based on observable factors including earnings consistency, relative price stability, and near-term catalyst alignment, Tickeron’s AI models would currently assign a modestly higher probability of favorable positioning to Danaher Corporation (DHR) over Medtronic plc (MDT). This assessment reflects DHR’s demonstrated quarterly outperformance and sector recovery signals versus MDT’s pending results and recent price pressure. The evaluation remains probabilistic and subject to new data such as upcoming earnings or macroeconomic shifts.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Hold and MDT is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DHR’s FA Score shows that 1 FA rating(s) are green whileMDT’s FA Score has 1 green FA rating(s).
- DHR’s FA Score: 1 green, 4 red.
- MDT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DHR’s TA Score shows that 5 TA indicator(s) are bullish while MDT’s TA Score has 6 bullish TA indicator(s).
- DHR’s TA Score: 5 bullish, 5 bearish.
- MDT’s TA Score: 6 bullish, 4 bearish.
Price Growth
DHR (@Medical Specialties) experienced а -1.31% price change this week, while MDT (@Medical/Nursing Services) price change was -0.85% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +7.62%. For the same industry, the average monthly price growth was +8.26%, and the average quarterly price growth was +2.13%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +15.47%. For the same industry, the average monthly price growth was +11.47%, and the average quarterly price growth was -5.49%.
Reported Earning Dates
DHR is expected to report earnings on Jul 21, 2026.
MDT is expected to report earnings on Aug 25, 2026.
Industries' Descriptions
@Medical Specialties (+7.62% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (+15.47% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| DHR | MDT | DHR / MDT | |
| Capitalization | 127B | 103B | 123% |
| EBITDA | 7.08B | 9.36B | 76% |
| Gain YTD | -21.653 | -15.378 | 141% |
| P/E Ratio | 34.53 | 21.25 | 162% |
| Revenue | 24.8B | 35.5B | 70% |
| Total Cash | 5.7B | 8.38B | 68% |
| Total Debt | 18.5B | 28.1B | 66% |
DHR | MDT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 80 | 74 | |
PRICE GROWTH RATING 1..100 | 60 | 60 | |
P/E GROWTH RATING 1..100 | 60 | 62 | |
SEASONALITY SCORE 1..100 | 26 | 23 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MDT's Valuation (3) in the Medical Specialties industry is in the same range as DHR (10). This means that MDT’s stock grew similarly to DHR’s over the last 12 months.
MDT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as DHR (100). This means that MDT’s stock grew similarly to DHR’s over the last 12 months.
MDT's SMR Rating (74) in the Medical Specialties industry is in the same range as DHR (80). This means that MDT’s stock grew similarly to DHR’s over the last 12 months.
MDT's Price Growth Rating (60) in the Medical Specialties industry is in the same range as DHR (60). This means that MDT’s stock grew similarly to DHR’s over the last 12 months.
DHR's P/E Growth Rating (60) in the Medical Specialties industry is in the same range as MDT (62). This means that DHR’s stock grew similarly to MDT’s over the last 12 months.
| DHR | MDT | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 56% | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 56% |
| Momentum ODDS (%) | 2 days ago 64% | 2 days ago 50% |
| MACD ODDS (%) | 2 days ago 67% | 2 days ago 49% |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 52% |
| TrendMonth ODDS (%) | 2 days ago 54% | 2 days ago 45% |
| Advances ODDS (%) | 2 days ago 54% | 9 days ago 51% |
| Declines ODDS (%) | 7 days ago 60% | 17 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 60% | 2 days ago 60% |
| Aroon ODDS (%) | 2 days ago 51% | 2 days ago 54% |
Advertisement
DHR and
Correlation & Price change
A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To DHR | 1D Price Change % | ||
|---|---|---|---|---|
| DHR | 100% | +0.44% | ||
| TMO - DHR | 77% Closely correlated | +1.15% | ||
| A - DHR | 73% Closely correlated | +0.14% | ||
| RGEN - DHR | 68% Closely correlated | -0.14% | ||
| RVTY - DHR | 64% Loosely correlated | +0.87% | ||
| BIO - DHR | 64% Loosely correlated | -3.84% | ||
More | ||||
MDT and
Correlation & Price change
A.I.dvisor indicates that over the last year, MDT has been loosely correlated with SYK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MDT jumps, then SYK could also see price increases.